XXXXXXXXXXXXX XXXXXXXXXX Sample Clauses

XXXXXXXXXXXXX XXXXXXXXXX. Xxxxxxxxxx Xxxxxx Board of Commissioners By: Name and Title, Printed Date: By: Name and Title, Printed Date: By: ATTEST: By: Name and Title, Printed Date: This instrument was prepared by the undersigned attorney: Date: Attorney: Indiana Department of Transportation 000 X. Xxxxxx Xxxxxx Xxxxxxxxxxxx, XX 00000 ATTACHMENT A PROJECT DESCRIPTION Des No: 2002907 Program: Local Roads and Bridges Matching Grants Route Name From To CR 75E 0.36 miles south of CR 600N 0.38 miles south of CR 600N Type of Project: Location: Bridge Deck Overlay Application ID: 10257 A general scope/description of the Project is as follows: The Bridge 79-00170 (NBI 7900113) project includes deck patching, a silica fume deck overlay, new bridge and approach rail improvements as well as approach pavement overlays. The attached Engineer?s Estimate provides a full listing of pay items included at this sightThe attached Map indicates the various Bridge Locations. Knowing that not all applications may be awarded, the applications have been prioritized in order of importance. The maximum amount of state funds allocated to the Project is $81,425.00 N758 - Local Programs ATTACHMENT B AWARD LETTER December 17, 2020 Tippecanoe County Xxx Xxxxxxxx 00 Xxxxx 0xx Xxxxxx Xxxxxxxxx, XX 00000 RE: Community Crossing Matching Grant Fund 2020-2 Award Letter Dear Xxx Xxxxxxxx: The Indiana Department of Transportation (INDOT) has completed the review and selection of projects for funding in the 2020-2 Community Crossings Matching Grant Fund Program. Your community has preliminarily been awarded Community Crossings Matching Grant Funds based upon your estimates the following: Application ID Preliminary Awarded Amount Location Priority 9894 $34,300.00 All 10255 $34,300.00 All 10256 $129,694.00 All 10257 $81,425.00 All 10258 $53,325.00 All 10260 $142,095.00 All 10262 $124,860.00 All TOTAL $599,999.00 Preliminary award amounts are contigent upon the following: INDOT must receive a copy of the fully-executed contract with a contractor or material supplier. Contractor/material supply contracts must be submitted no later than four (4) months from the date of this award letter. Failure to meet this date will result in the forfeiture of your funds. Local Public Agency (LPA) must sign and return the LPA-INDOT Grant Agreement no later than two (2) months from the date of this award letter. Signatures cannot be over 30 days old once it reaches the INDOT LPA/MPO Division Office located in Indianapolis. Failure to meet this...
Sample 1
AutoNDA by SimpleDocs
XXXXXXXXXXXXX XXXXXXXXXX. 15.1 This Agreement shall be construed, governed, interpreted and applied in accordance with the laws of the State of Texas, U.S.A., except that questions affecting the construction and effect of any patent shall be determined by the law of the country in which the patent was granted.
Sample 1Sample 2
XXXXXXXXXXXXX XXXXXXXXXX. Xxxxxxxxxx Xxxxxx Board of Commissioners By: Name and Title, Printed Date: By: Name and Title, Printed Date: By: ATTEST: By: Name and Title, Printed Date: This instrument was prepared by the undersigned attorney: Date: Attorney: Indiana Department of Transportation 000 X. Xxxxxx Xxxxxx Xxxxxxxxxxxx, XX 00000 ATTACHMENT A PROJECT DESCRIPTION Des No: 2002904
Sample 1
XXXXXXXXXXXXX XXXXXXXXXX. XXX’s and/or Xxxxxx Switzerland’s obligation, as applicable, to reimburse the Administrative Agent and the Lenders on account of any drawing under any Letter of Credit as provided in §4.2.
Sample 1
XXXXXXXXXXXXX XXXXXXXXXX. Xxxxx Xxxxxx GlaxoSmithKline’s manufacturing business at Cape Town Finalisation and implementation of agreed separation plan for asset transfer to ensure continuity of supply in all markets supplied by the manufacturing site including regulatory compliance, alignment to Product License transfer and distribution cutover plan and artwork change scheduling. Mexico GlaxoSmithKline’s manufacturing business at Civac Finalisation and implementation of agreed separation plan for asset transfer to ensure continuity of supply in all markets supplied by the manufacturing site including regulatory compliance, alignment to Product License transfer and distribution cutover plan and artwork change scheduling. Australia GlaxoSmithKline’s manufacturing business at Ermington Finalisation and implementation of agreed separation plan for asset transfer to ensure continuity of supply in all markets supplied by the manufacturing site including regulatory compliance, alignment to Product License transfer and distribution cutover plan and artwork change scheduling. Ireland GlaxoSmithKline’s manufacturing business at Sligo Finalisation and implementation of agreed separation plan for asset transfer to ensure continuity of supply in all markets supplied by the manufacturing site including regulatory compliance, alignment to Product License transfer and distribution cutover plan and artwork change scheduling. UK GlaxoSmithKline’s manufacturing business at Maidenhead GlaxoSmithKline’s manufacturing business at Slough (Excluding employees) Finalisation and implementation of agreed separation plan for asset transfer to ensure continuity of supply in all markets supplied by the manufacturing site including regulatory compliance, alignment to Product License transfer and distribution cutover plan and artwork change scheduling. US GlaxoSmithKline’s manufacturing business at Oak Hill GlaxoSmithKline’s manufacturing business at St Louis GlaxoSmithKline’s manufacturing business at Aiken (Excluding employees) Finalisation and implementation of agreed separation plan for asset transfer to ensure continuity of supply in all markets supplied by the manufacturing site including regulatory compliance, alignment to Product License transfer and distribution cutover plan and artwork change scheduling. Appendix 3 Delayed Assets
Sample 1
XXXXXXXXXXXXX XXXXXXXXXX. (x) This Agreement is an integrated agreement and, except for the agreements contemplated herein and the escrow instructions to accomplish this agreement (including the Undertakings Agreement), it contains the entire understanding between the parties with respect to the transaction contemplated herein, and all prior agreements, understandings, representations and statements, oral or written are merged into this Agreement. The delivery of the deed by Seller will be deemed the full performance and discharge of every obligation on the part of Seller to be performed hereunder, except for any obligations of Seller which are expressly provided herein to survive the closing. No provision of this Agreement may be waived except by an instrument signed by the party against whom the enforcement of such waiver is sought. All modifications (including any extensions) of this Agreement will be effective only if signed by Seller and Buyer.
Sample 1
XXXXXXXXXXXXX XXXXXXXXXX. 00 00. All of the Exhibits attached hereto are hereby incorporated herein by reference as 16 though fully set forth herein. Notwithstanding the foregoing, in the event of a conflict or 17 inconsistency between the terms of this Stipulation and the terms of any Exhibit attached hereto, 18 the terms of this Stipulation shall prevail.
Sample 1
AutoNDA by SimpleDocs
XXXXXXXXXXXXX XXXXXXXXXX. The Board of Directors of the Louisiana Society of Health-System Pharmacists invites you to participate as an exhibitor and/or sponsor for the LSHP 2019 Mid Year Meeting, which will be held Saturday, September 28 at the Shreveport Convention Center, 000 Xxxxx Xx, Xxxxxxxxxx, XX 00000. Our Mid Year Meeting draws approximately 130-150 participants. This is a one-day meeting with the opportunity for our registrants to gain about 7 hours of continuing education credit. LSHP members represent more than 180 hospitals in Louisiana, many of which are clinical pharmacists and administrative decision makers at their institutions. As an exhibitor, you will receive one table at our exhibition for two representatives. Our exhibition area will be open from 11:00 a.m.-1:00 p.m. on Saturday, September 28, including an hour of exhibit time and an hour available for lunching with registrants allowing you a great opportunity to meet with LSHP pharmacists and pharmacy technicians one-on-one. This is an excellent business opportunity and a way to show your support of your local pharmacists. An exhibit agreement and registration are found on the following pages and should be submitted to LSHP at the above address. If you are interested in becoming a sponsor, there are many ways to support LSHP and the Mid Year Meeting. Sponsorship opportunities are listed on the fourth page and are available even if you are unable to attend the meeting. If you have any questions regarding exhibiting or sponsorship, please don’t hesitate to call Xxxxx Xxxxxx, Association Coordinator at the LSHP office. The LSHP tax id number is 72- 0859040. Again this year, LSHP is offering a “Reverse Expo,” on Friday, September 27th, 2019, where hospital pharmacy decision makers (pharmacy directors and/or clinical managers) will each host a table while vendors walk the floor. Please see page 7 of this document for more information! Your support of LSHP and its programs demonstrates your professional commitment and support of pharmacists in Louisiana. This support is both recognized and appreciated by the Board of Directors and membership of LSHP. On behalf of the Executive Committee and the Board of Directors of LSHP, we would like to thank you in advance for your continued support. Sincerely,
Sample 1

Related to XXXXXXXXXXXXX XXXXXXXXXX

  • Xxxxxxxx Xxxxxxxxx Xx xxxvided for in the Agreement and Declaration of Trust of the various Funds, under which the Funds are organized as unincorporated trusts, the shareholders, trustees, officers, employees and other agents of the Fund shall not personally be found by or liable for the matters set forth hereto, nor shall resort be had to their private property for the satisfaction of any obligation or claim hereunder.

  • XXXXXXXXXXXXX The captions in this Agreement are included for convenience of reference only, and in no way define or delimit any of the provisions hereof or otherwise affect their construction or effect. This Agreement may be executed simultaneously in two or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

  • Xxxxxxxxxxxx This Agreement may be executed in one or more counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument.

  • Xxxxxxxx Xxxxxxxx obligation to pay compensation to PaineWebber as agreed upon pursuant to this paragraph 4 is not contingent upon receipt by Xxxxxxxx Xxxxxxxx of any compensation from the Fund or Series. Xxxxxxxx Xxxxxxxx shall advise the Board of any agreements or revised agreements as to compensation to be paid by Xxxxxxxx Xxxxxxxx to PaineWebber at their first regular meeting held after such agreement but shall not be required to obtain prior approval for such agreements from the Board.

  • Xxxxxxxxxxxxxx XX.Xxx as a Microsoft Excel Spreadsheet or some other mutually agreeable standardized format (CSV, MDB, etc.).

  • Xxxxxxxxxxx 12.1 In addition to the specific rights of termination set out in the Clause "The Publisher's Responsibilities" and the Clause "The Author's Responsibilities", either Party shall be entitled to terminate this Agreement forthwith by notice in writing to the other Party if the other Party commits a material breach of the terms of the Agreement which cannot be remedied or, if such breach can be remedied, fails to remedy such breach within 45 days of being given written notice to do so.

  • Xxxxxxxxxx A grievance may be withdrawn at any time.

  • Xxxxxxxxxxx X Xxxx, Esq., shall have furnished to the Underwriters his written opinion, as Corporate Counsel of the Enterprise Parties, addressed to the Underwriters and dated such Delivery Date, in form and substance reasonably satisfactory to the Underwriters, substantially to the effect set forth in Exhibit B hereto.

  • Xxxxxxxxxx Xxxxx Xxx xxxx xxx xxxxxxx xx the registered agent of the LLC for service of process on the LLC in the State of Delaware is National Registered Agents, Inc., 9 East Loockerman Street, Suite 1B, Dover, Delaware 19901.

  • Xxxxxx Xxxxxxxxx Purchase Order and Sales Contact Email Please enter a valid email address that will definitely reach the Purchase Order and Sales Contact. 2 2 xxxxxx@xxxxxxxxxxxxxxx.xxx Purchase Order and Sales Contact Phone Numbers only, no symbols or spaces (Ex. 8668398477). The system will auto-populate your entry with commas once submitted which is appropriate and expected (Ex. 8,668,398,477). 2 3 8324187951 Company Website Company Website (Format - xxx.xxxxxxx.xxx) 4 No response Entity D/B/A's and Assumed Names You must confirm that you are responding to this solicitation under your legal entity name. Go now to your Supplier Profile in this eBid System and confirm that your profile reflects your "Legal Name" as it is listed on your W9. In this question, please identify all of your entity's assumed names and D/B/A's. Please note that you will be identified publicly by the Legal Name under which you respond to this solicitation unless you organize otherwise with TIPS after award. 5 No response Primary Address Primary Address 2 6 00000 Xxxxxxxxxx 00 X, Xxxxx 000 Primary Address City Primary Address City 7 Spring Primary Address State Primary Address State (2 Digit Abbreviation) 2 8 TX Primary Address Zip Primary Address Zip 9 77380 Search Words Identifying Vendor Please list all search words and phrases to be included in the TIPS database related to your entity. Do not list words which are not associated with the bid category/scope (See bid title for general scope). This will help users find you through the TIPS website search function. You may include product names, manufacturers, specialized services, and other words associated with the scope of this solicitation.

Time is Money Join Law Insider Premium to draft better contracts faster.